JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome - PubMed (original) (raw)
JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome
C Crosnier et al. Hepatology. 2000 Sep.
Abstract
Mutations of the JAGGED1 gene, encoding a NOTCH receptor ligand, cause Alagille syndrome (AGS), a complex malformative disorder affecting mainly the liver, heart, vertebrae, eye, and face. Minor and occasional features involving kidney, pharynx, systemic arteries, skeleton, and ear are in some cases associated with the syndrome. To describe the expression of JAGGED1 during human embryogenesis and to study its relationship with all the features of AGS, we performed in situ hybridization studies on human embryos and fetal tissue sections. JAGGED1 was mainly expressed in the cardiovascular system. In the liver, JAGGED1 transcripts were only detected in blood vessels. JAGGED1 was also expressed in other structures of mesenchymal origin (distal mesenchyme of limb buds; mesonephric and metanephric tubules of the kidney) and in epithelial structures including the ciliary margin of the retina and the posterior part of the lens, the ventral epithelium of the otic vesicle, the neurosensory epithelium of the ear vestibule, the epithelium of pharyngeal arches, and the developing central nervous system. The strong JAGGED1 expression during human embryo- and feto-genesis both in the vascular system and in other mesenchymal and epithelial tissues implicates abnormal angiogenesis in the pathogenesis of Alagille syndrome and particularly the paucity of interlobular bile ducts. However, it is probably not the only mechanism of the disease. Except for the central nervous system, there is a strong correlation between JAGGED1 expression and all the features of AGS. This implies that the features occasionally associated with the syndrome are not coincidental.
Similar articles
- Alagille syndrome and the Jagged1 gene.
Piccoli DA, Spinner NB. Piccoli DA, et al. Semin Liver Dis. 2001 Nov;21(4):525-34. doi: 10.1055/s-2001-19036. Semin Liver Dis. 2001. PMID: 11745040 Review. - JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype.
Jones EA, Clement-Jones M, Wilson DI. Jones EA, et al. J Med Genet. 2000 Sep;37(9):658-62. doi: 10.1136/jmg.37.9.658. J Med Genet. 2000. PMID: 10978356 Free PMC article. - Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome population.
Heritage ML, MacMillan JC, Colliton RP, Genin A, Spinner NB, Anderson GJ. Heritage ML, et al. Hum Mutat. 2000 Nov;16(5):408-16. doi: 10.1002/1098-1004(200011)16:5<408::AID-HUMU5>3.0.CO;2-9. Hum Mutat. 2000. PMID: 11058898 - [From gene to disease: arteriohepatic dysplasia or Alagille syndrome].
Brooks AS, Dooijes D. Brooks AS, et al. Ned Tijdschr Geneeskd. 2003 Jun 21;147(25):1213-5. Ned Tijdschr Geneeskd. 2003. PMID: 12848056 Review. Dutch. - Alagille syndrome. The widening spectrum of arteriohepatic dysplasia.
Crosnier C, Lykavieris P, Meunier-Rotival M, Hadchouel M. Crosnier C, et al. Clin Liver Dis. 2000 Nov;4(4):765-78. doi: 10.1016/s1089-3261(05)70140-9. Clin Liver Dis. 2000. PMID: 11232356 Review.
Cited by
- Sex differences and risk factors for bleeding in Alagille syndrome.
Hankeova S, Van Hul N, Laznovsky J, Verboven E, Mangold K, Hensens N, Adori C, Verhoef E, Zikmund T, Dawit F, Kavkova M, Salplachta J, Sjöqvist M, Johansson BR, Hassan MG, Fredriksson L, Baumgärtel K, Bryja V, Lendahl U, Jheon A, Alten F, Fahnehjelm KT, Fischler B, Kaiser J, Andersson ER. Hankeova S, et al. EMBO Mol Med. 2022 Dec 7;14(12):e15809. doi: 10.15252/emmm.202215809. Epub 2022 Nov 8. EMBO Mol Med. 2022. PMID: 36345711 Free PMC article. - Role of Jagged1-Notch pathway in thyroid development.
Marelli F, Persani L. Marelli F, et al. J Endocrinol Invest. 2018 Jan;41(1):75-81. doi: 10.1007/s40618-017-0715-x. Epub 2017 Jun 26. J Endocrinol Invest. 2018. PMID: 28653287 Review. - Characterization of the human fetal gonad and reproductive tract by single-cell transcriptomics.
Taelman J, Czukiewska SM, Moustakas I, Chang YW, Hillenius S, van der Helm T, van der Meeren LE, Mei H, Fan X, Chuva de Sousa Lopes SM. Taelman J, et al. Dev Cell. 2024 Feb 26;59(4):529-544.e5. doi: 10.1016/j.devcel.2024.01.006. Epub 2024 Jan 30. Dev Cell. 2024. PMID: 38295793 Free PMC article. - Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells.
Yamamura H, Yamamura A, Ko EA, Pohl NM, Smith KA, Zeifman A, Powell FL, Thistlethwaite PA, Yuan JX. Yamamura H, et al. Am J Physiol Cell Physiol. 2014 May 1;306(9):C871-8. doi: 10.1152/ajpcell.00221.2013. Epub 2014 Feb 26. Am J Physiol Cell Physiol. 2014. PMID: 24573085 Free PMC article. - Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome.
Delaney S, O'Connor G, Reardon W, Murphy SJX, Tierney S, Ryan BM, Delaney H, Doherty CP, Guiney M, Brennan P, Tobin WO, McCabe DJH. Delaney S, et al. Front Neurol. 2019 Jan 29;9:1194. doi: 10.3389/fneur.2018.01194. eCollection 2018. Front Neurol. 2019. PMID: 30761079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources